The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study

References

• Mburu J, Odame I. Sickle cell disease: reducing the global disease burden. Int J Lab Hematol. 2019;41(Suppl 1):82–88. doi:10.1111/ijlh.13023
   PubMed Web of Science ®Google Scholar
• Piel FB, Steinberg MH, Rees DC, Longo DL. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. doi:10.1056/NEJMra1510865
   PubMed Web of Science ®Google Scholar
• United States Census Bureau. 2008 national population projections datasets. Table 1, Projected population by age, sex, race, and Hispanic origin: July 1, 2000 to July 1, 2050. U.S. Census bureau; 2022. Available frrom: https://www.census.gov/data/datasets/2008/demo/popproj/2008-popproj.html. Accessed December 27, 2022.
   Google Scholar
• Dormandy E, James J, Inusa B, et al. How many people have sickle cell disease in the UK? J Public Health. 2018;40(3):e291–e295. doi:10.1093/pubmed/fdx172
   Google Scholar
• Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (Sub-Saharan Africa). Anemia. 2015;2015:791498.
   PubMed Web of Science ®Google Scholar
• Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, et al. The prevalence of sickle cell disease in Saudi children and adolescents. A Community-Based Survey. Saudi Med J. 2008;29:1480–1483.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31:229–235. doi:10.4103/0256-4947.81527
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. Overview of the clinical manifestations of sickle cell disease. In: Post TW, editor. UpToDate. Waltham, MA: UpToDate Inc; 2022. Available from: https://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-sickle-cell-disease. Accessed December 27, 2022.
   Google Scholar
• Lanzkron S, Carroll CP, Haywood CJ. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol. 2010;85:797–799. doi:10.1002/ajh.21807
   PubMed Web of Science ®Google Scholar
• Cronin RM, Hankins JS, Byrd J, et al. Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology. 2019;24:189–198. doi:10.1080/16078454.2018.1549801
   PubMed Web of Science ®Google Scholar
• Alkindi S, Altooq J, Dewedar H, et al. S113: cost Of Illness, Epidemiology And Healthcare Resource Utilization For Sickle Cell Disease In Gulf Countries (Cescgu). Hemasphere. 2022;6(Suppl):7. doi:10.1097/01.HS9.0000821420.25455.37
   Google Scholar
• Osunkwo I, Andemariam B, Minniti CP, et al. Impact of sickle cell disease on patients’ daily lives, symptoms reported, and disease management strategies: results from the international sickle cell world Assessment Survey (SWAY). Am J Hematol. 2021;96:404–417. doi:10.1002/ajh.26063
   PubMed Web of Science ®Google Scholar
• Adam SS, Flahiff CM, Kamble S, et al. Depression, quality of life, and medical resource utilization in sickle cell disease. Blood Adv. 2017;1:1983–1992. doi:10.1182/bloodadvances.2017006940
   PubMed Web of Science ®Google Scholar
• Gosadi IM. National screening programs in Saudi Arabia: overview, outcomes, and effectiveness. J Infect Public Health. 2019;12:608–614. doi:10.1016/j.jiph.2019.06.001
   PubMed Web of Science ®Google Scholar
• General Authority for Statistics (GASTAT). The Labor Market Publication for the second quarter of 2022. Available from https://www.stats.gov.sa/en/6800. Accessed December 27, 2022.
   Google Scholar
• General Authority for Statistics (GASTAT). Household income and expenditure survey; 2018. Available from: https://www.stats.gov.sa/en/37. Accessed September 21, 2022.
   Google Scholar
• Candrilli SD, O’Brien SH, Ware RE, et al. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol. 2011;86(3):273–277. doi:10.1002/ajh.21968
   PubMed Web of Science ®Google Scholar
• Badawy SM, Thompson AA, Lai J-S, et al. Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults. Health Qual Life Outcomes. 2017;15(1):136. doi:10.1186/s12955-017-0713-x
   PubMed Web of Science ®Google Scholar
• Agrawal RK, Patel RK, Shah V, et al. Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus. 2014;30(2):91–96. doi:10.1007/s12288-013-0261-4
   PubMed Web of Science ®Google Scholar
• Colombatti R, Palazzi G, Masera N, et al. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: results of a National Multicenter survey. Pediatr Blood Cancer. 2018;65(2):10. doi:10.1002/pbc.26774
   Web of Science ®Google Scholar
• Althumiri NA, Basyouni MH, AlMousa N, et al. Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthcare. 2021;9:311. doi:10.3390/healthcare9030311
   Web of Science ®Google Scholar
• Jan H, Waheeb A, AlAhwal H, et al. COVID-19 vaccine perception and hesitancy among patients with sickle cell disease in the western region of Saudi Arabia. Cureus. 2022;14:e21026. doi:10.7759/cureus.21026
   PubMed Web of Science ®Google Scholar
• Steiner CA, Miller JL. Sickle cell disease patients in U.S. Hospitals. 2004. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.
   Google Scholar
• Shah N, Bhor M, Xie L, et al. Sickle cell disease complications: prevalence and resource utilization. PLoS One. 2019;14:e0214355. doi:10.1371/journal.pone.0214355
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855–1865.
   PubMed Web of Science ®Google Scholar
• Bartolucci P, Habibi A, Khellaf M, et al. Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients. EBiomedicine. 2016;10:305–311. doi:10.1016/j.ebiom.2016.06.038
   PubMed Web of Science ®Google Scholar
• Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325:1476–1481. doi:10.1056/NEJM199111213252104
   PubMed Web of Science ®Google Scholar
• Akinyoola AL, Adediran IA, Asaleye CM. Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J. 2007;14:217–220.
   PubMedGoogle Scholar
• Aljuburi G, Phekoo KJ, Okoye NO, et al. Patients’ views on improving sickle cell disease management in primary care: focus group discussion. JRSM Short Rep. 2012;3:84. doi:10.1258/shorts.2012.011153
   PubMedGoogle Scholar